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Noninvasive quantitative mapping of predominantly classic 
CNV by RTA is feasible and also allows 3-dimensional mea-
surement of the lesion itself. The results correlate well with 
FA assessment but visualize different properties of the dis-
ease.  Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 Age-related macular degeneration is a leading cause of 
legal blindness in the Western World with an increasing 
incidence and prevalence  [1, 2] . Especially the ‘wet forms’ 
due to choroidal neovascularization (CNV) account for 
the majority of rapid and severe visual loss. Based on the 
fluorescein angiography (FA) appearance, CNVs are cur-
rently subdivided into occult and classic forms. From a 
well-established therapy for classic membranes, photo-
dynamic therapy (PDT), this subtype is known to exhib-
it typical biological features making it treatable by PDT. 
Due to relatively high recurrence rates, a close follow-up 
is needed, conventionally performed by FA. Less invasive 
and faster diagnostic approaches for diagnosis and fol-
low-up are desirable, which might be obtained by cross-
sectioning imaging devices such as optical coherence to-
mography (OCT, Carl-Zeiss Meditec, Jena, Germany) or 
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 Abstract 
 Purpose: To compare and correlate imaging of classic subfo-
veal choroidal neovascularization (CNV) with noninvasive 3-
dimensional imaging by the retinal thickness analyzer (RTA) 
to conventional fluorescein angiography (FA).  Methods: A 
total of 29 eyes of 29 consecutive patients with predomi-
nantly classic CNV eligible for photodynamic therapy  under-
went FA and RTA imaging. The FA dimensions of the CNV 
were measured independently by two graders. With the 
RTA, masked to FA the size of the CNV itself as imaged in 3-
dimensional reconstruction, the size of significantly thick-
ened retina overlying the CNV and the maximum retinal 
thickness were measured.  Results: The mean diameter of 
the CNV determined from 3-dimensional RTA reconstruc-
tions showed an excellent correlation with measurements 
from FA (r = 0.91, p  ! 0.001). The area of retinal thickening 
was by a mean of 0.7 mm in diameter larger and correlated 
moderately well with the size of the CNV on FA (r = 0.65, p  ! 
0.001). In contrast, there was no correlation between the ab-
solute retinal thickness and the CNV size on FA.  Conclusions: 
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the retinal thickness analyzer (RTA). The RTA (Talia 
Technology, Lod Indst. Area, Israel) is an imaging device 
originally designed for the mapping of macular edema 
and objective measurements of retinal thickness at the 
posterior pole  [3–6] . The RTA calculates the retinal thick-
ness from the difference between the vitreoretinal and 
the chorioretinal surface. Imaging is fast enough to avoid 
any motion artifacts and covers an area of 3  ! 3 mm with 
each scan. Consecutively, also 3-dimensional mapping of 
the retina and retinal pigment epithelium (RPE) layer can 
be performed by the same technology  [7] including C-
scan-like viewing and slicing of the resulting voxel block. 
Imaging classic CNV with the instrument might facili-
tate follow-up and might reduce the number of FA ex-
aminations necessary, if sufficient information could be 
obtained. Therefore as a fist step the current study inves-
tigates the correlation of cross-sectional and 3-dimen-
sional RTA imaging of classic CNVs with their fluores-
cein angiographic properties. 
 Methods 
 Patients 
 Twenty-nine eyes of 29 consecutive patients with predomi-
nantly classic, subfoveal CNV due to age-related macular degen-
eration eligible for PDT according to the original TAP criteria  [8] 
were included. Patients were also eligible when PDT was per-
formed for classic but juxtafoveal CNV  [9] . All patients under-
went conventional FA and RTA scanning on the same day in 
 random order at the Department of Ophthalmology, Ludwig-
Maximilians-Universität, Munich, Germany. Eyes with other co-
existing retinal disease or any significant media opacities were 
excluded. Research was conducted after informed consent had 
been obtained from each patient and conformed to the tenets of 
the World Medical   Association Declaration of Helsinki. In total, 
there were 12 right and 17 left eyes of 29 patients assigned to this 
study (11 male, 18 female). In the highly selected group of patients 
eligible for PDT by the criteria given above, no eyes had to be ex-
cluded, especially not for image quality of any instrument. Age 
ranged from 60 to 84 years with a mean age of 75  8 9.1 years ( 8 
standard deviation). Refraction ranged in spherical equivalent 
between –5 and +4.5 dpt. Best corrected visual acuity ranged from 
20/200 to 20/40 (median 20/100). 
 Fluorescein Angiography 
 Routine FA was performed after rapid injection of 5 ml of a 
20% solution of fluorescein (Ciba Vision Ophthalmics, Toulouse, 
France). A series of digital fundus pictures was taken with a scan-
ning laser ophthalmoscope (Heidelberg Retina Angiograph; Hei-
delberg Engineering, Heidelberg, Germany). From each series, a 
picture from the early phase (10–20 s) and a picture from the lat-
er phase (3–5 min) showing the sharpest boundaries of the lesion 
were selected for analysis ( fig. 1 A, B). The CNV was defined to be 
classic if a discrete, well-demarcated focal area of hyperfluores-
cence was detectable in the early phase with fluorescein leakage 
in late frames  [11] . Analysis of fluorescein angiograms consisted 
of measurement of the CNV dimensions (maximum diameter 
with all directions considered) independently by two masked 
graders. The mean of the two graders was used as a reference, ab-
solute sizes were calculated by the Heidelberg Retina Angio-
graph’s proprietary software program taking into account an ap-
propriate magnification factor dependent on the instrument and 
characteristics of the eye such as refraction  [12] . 
 RTA Measurements 
 All patients were scanned with the RTA equipped with a color 
fundus camera. The principles of measurement have been de-
scribed in detail elsewhere  [5, 6] . With the instrument version 
used, 16 optical cross-section images covering an area of 3  ! 
3 mm on the retina are acquired in 300 ms during 1 scan. These 
optical sections are thus spaced approximately 190   m apart. The 
posterior pole is completely covered in 5 overlapping scans and a 
retinal thickness map is automatically composed ( fig. 1 C). For the 
current study the instrument’s equidistant quadratic coverage of 
the posterior pole with several motion-free scans is important, 
which allows 3-dimensional display and analysis of the resulting 
voxel blocks. Appropriate fixation was verified by observing a 
fundus image (and the projection and recording of the fixation 
mark) that is acquired simultaneously. Analysis consisted of ab-
solute maximum retinal thickness measurements (intraretinal 
edema overlying the CNV), the area of abnormal thickening and 
finally assessment of the size of the CNV. Of these the maximum 
retinal thickness and the area of significant thickening were cal-
culated by the instrument’s built-in software (version 4.11B). 
Maximum thickness and the maximal diameter of significant ret-
inal thickening (outside the instrument’s normative database) 
were obtained from the standard thickness maps.  
 The size of the CNV (maximum diameter) was assessed from 
the 3-dimensional display of the slit images of the RTA in a 
masked manner by one experienced observer (R.W.S.). This was 
performed in detail by determining the extension of higher re-
flectivity and anterior displacement at the posterior part of the 
slits, which corresponds to the RPE level. Such higher reflectiv-
ity at the posterior RPE level is assumed to be caused by the CNV 
itself  [10, 13] and does not include exudation. Therefore, those 
measurements should correspond to the real maximum CNV 
diameter. Manual measurements were performed on 3-dimen-
sional and reversely displayed data sets with the instrument’s 
Anatomy Imager software. An example is shown in  figure 1 il-
lustrating the highly reflective CNV on the cross-section slits 
( fig. 1 D) and their viewing in 3-dimensional display ( fig. 1 E), 
which greatly facilitates defining the borders to measure CNV 
size. If the identified lesion extended over one single 3  ! 3 mm 
RTA scan, which occurred in 7/29 eyes, the maximum extension 
on both adjacent scans was measured and added. This is possi-
ble, as the scans are registered by the instrument’s software on 
the fundus image allowing exact localization. In no case did the 
lesion extend over the 6  ! 6 mm area of the posterior pole cov-
ered by RTA scanning. While the resolution of thickness mea-
surements in the x-y plane over the posterior pole is 190   m, the 
3-dimensional display  technique as applied here may have a 
much higher spatial resolution – at least in the y-axis direction 
where the complete slit images are shown with 256 pixels over 3 
mm distance, i.e. 11.7   m spaced apart. As the simultaneously 
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taken color fundus photograph can be superimposed on the 3-
dimensional voxel block, the x-y resolution might be improved 
by this means for clinical measurements related to the retinal 
surface – a technique not used in the current study where reverse 
viewing of the CNV from below was applied. For statistical anal-
ysis, SPSS for Windows (SPSS Inc., Chicago, Ill., USA), version 
12.0, was used; p  ! 0.05 was considered significant and p  6 0.05 
nonsignificant (n.s.). 
 Results 
 The maximum diameter of the CNV determined by 
FA was obtained from two graders, which showed an ex-
cellent correlation (r = 0.918, p  ! 0.001); its mean was 2.3 
 8 0.9 mm ( 8 standard deviation). The maximum diam-
eter of the CNV as determined from RTA imaging was 
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 Fig. 1. Example of a predominantly classic 
CNV.  A Early phase of the fluorescein an-
giogram. Note the well-demarcated area of 
hyperfluorescence indicating the area of 
neovascularization which measured a 
maximum diameter of 1.46 mm.  B Late 
phase of FA with increasing leakage at the 
site of the lesion.  C Retinal thickness de-
viation from the normal database of the 
RTA. The diameter of significant thicken-
ing was determined on this map, in this 
case 1.5 mm horizontally as measured in 
the instrument’s analysis software. Hori-
zontal and vertical measurements were 
performed on the deviation map for com-
parison with FA.  D Slit image of the RTA 
center scan, encompassing an area of 3  ! 
3 mm. The CNV is encircled in yellow by 
determining the maximum diameter of 
higher reflectivity at the posterior part of 
the slit (to the right, corresponding to the 
RPE level), which is assumed to be caused 
by or to represent the CNV  [10] . The diam-
eter of altered reflectivity measured man-
ually in the slit analysis of the RTA soft-
ware yields a maximum of 1.5 mm. Al-
though this method is theoretically 
feasible, measurements are much facilitat-
ed by the 3-dimensional display technique 
as shown in  E .  E Three-dimensional dis-
play of the same 3  ! 3 mm area as in  D . 
The 3-dimensional voxel block is viewed 
from the chorioretinal side (‘upside down’) 
with the Anatomy Imager software. The 
chorioretinal side is slightly sectioned 
while viewed from downside to define the 
extent of the classic CNV in the left part of 
the image. It measures approximately 1.5 
mm in maximum diameter, a caliper is 
shown. 
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not statistically different with a mean of 2.5  8 1.0 mm
(p = 0.19). The CNV diameters obtained from the two 
imaging modalities correlated well with each other (r = 
0.91, p  ! 0.001) as shown in  figure 2 . Detailed analysis of 
their differences yielded a significant but moderate cor-
relation (r = 0.46, p = 0.01) of the method difference with 
the size of the lesion as defined on FA: in small lesions the 
RTA CNV measurements tended to be relatively too large, 
while larger lesions showed fewer differences between the 
two modalities (n.s. for the larger half of the lesions). The 
difference in size between the two modalities also corre-
lated significantly with the classic percentage of the CNV 
(r = –0.40, p = 0.03): more occult lesions showed higher 
differences between the two imaging modalities than 
more classic lesions. 
 As shown in  figure 3 , the area of significant retinal 
thickening showed a significantly (p  ! 0.001) larger di-
ameter on RTA (3.0  8 1.2 mm) than on FA (2.3  8 0.9 
mm), but on the other hand the diameter on FA and the 
thickened retina area correlated well (r = 0.61, p  ! 0.001). 
The existing absolute differences between the diameter 
of the thickened retina on RTA and on FA correlated with 
the size of the thickened retina area as measured by RTA 
(r = 0.65, p  ! 0.001): for larger areas of thickening the RTA 
showed higher values and larger differences compared to 
the FA diameter ( fig. 3 ). However, an inverse, nonsignif-
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icant correlation was observed when the CNV size was 
defined by FA. In summary no definitive factor respon-
sible for the degree of discordance between the two imag-
ing modalities could be identified. Regarding retinal 
thickness (z-direction), the maximum absolute retinal 
thickness overlying the CNV measured a mean of 373  8 
93   m and did not correlate with the size of the CNV on 
FA (r = 0.1, p = 0.568). 
 Discussion 
 We could demonstrate that measuring classic CNV in 
age-related macular degeneration is feasible with a cross-
sectioning noninvasive imaging device, the RTA, and 
that CNV size measurements (at the RPE level) correlate 
well with those of FA. However, the area of retinal thick-
ening tends to be larger than that of the CNV, which may 
be explained by retinal edema adjacent to the CNV. Fluid 
accumulation, debris deposits, location of the CNV rela-
tive to the RPE and sensory retina, scarring, tissue atro-
phy (especially after PDT) and other factors may cause 
the area of retinal thickening to be larger than the CNV 
seen on FA. Peak retinal thickness does not correlate with 
the CNV size or any other parameter investigated: it may 
therefore rather reflect different amounts of leakage and 
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 Fig. 2. Bland-Altman plot of the maximum CNV diameter as de-
termined from the RTA 3-dimensional image analysis versus 
maximum diameter of the CNV on FA. An excellent correlation 
of the size determined from the RTA with the CNV size on FA 
was observed (r = 0.91, p  ! 0.001), means do not differ signifi-
cantly (p = 0.19). However, in some cases distinct differences of 
up to 1.35 mm exist. SD = Standard deviation. 
 Fig. 3. Maximum CNV diameter on FA versus the maximum 
 diameter of thickened retina as measured with the RTA. The 
thickened retina measured on RTA was by a mean of 0.7 mm (dot-
ted line) significantly larger (p = 0.001) than the CNV on FA, but 
a moderately good correlation with FA exists (r = 0.65, p  ! 
0.001). 
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might to some degree correspond with the activity of the 
lesion. Those results are in concordance with those from 
other groups investigating FA compared to OCT  [13, 14] . 
OCT and the RTA as applied in our study are known to 
give similar results in CNV imaging  [15] . 
 For the first time our study systematically quantifies 
the size of the CNV on cross-section and 3-dimensional 
reconstructed (RTA) images, for which an excellent cor-
relation with FA could be shown. The 3-dimensional dis-
play of the RTA data set in a C-scan-like fashion with the 
Anatomy Imager much facilitates correctly defining the 
area of the CNV. This is in agreement with studies apply-
ing OCT cross-sectioning, where OCT was found to be 
even more reliable than FA and indocyanine green angi-
ography  [10] and more recently OCT 3-dimensional im-
aging  [16] . One might speculate that the differences found 
between FA and morphological imaging – such as OCT 
or RTA – may rather reflect the different biological prop-
erties of the CNV than errors of either morphological or 
FA imaging  [14, 17] . Approaches to use the knowledge of 
those differences to modify e.g. PDT treatment regimens 
are promising  [18] . 
 Conclusions 
 In summary, noninvasive quantitative mapping of 
predominantly classic CNV by RTA is feasible and by 3-
dimensional viewing also allows measurement of the size 
of the lesion itself. The results correlate well with FA as-
sessment but visualize different properties of the dis-
ease. 
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